Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/monitoring-of-the-evolution-of-immune-checkpoint-inhibitor-myocarditis-v30gldVY0m
References (5)
-
L. Heinzerling, P. Ott, F. Hodi, A. Husain, Azadeh Tajmir-Riahi, H. Tawbi, M. Pauschinger, T. Gajewski, E. Lipson, J. Luke (2016)
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyJournal for Immunotherapy of Cancer, 4
-
Daniel Wang, G. Okoye, T. Neilan, Douglas Johnson, J. Moslehi (2017)
Cardiovascular Toxicities Associated with Cancer ImmunotherapiesCurrent Cardiology Reports, 19
-
G. Laine, S. Allen (1991)
Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function.Circulation research, 68 6
-
G. Laine, S. Allen (2005)
Lymph Flow, Interstitial Fibrosis, and Cardiac Function -
M. Friedrich, U. Sechtem, J. Schulz-Menger, G. Holmvang, P. Alakija, L. Cooper, James White, H. Abdel-Aty, M. Gutberlet, S. Prasad, A. Aletras, J. Laissy, I. Paterson, N. Filipchuk, Andreas Kumar, M. Pauschinger, P. Liu (2009)
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.Journal of the American College of Cardiology, 53 17
- Publisher
- Wolters Kluwer Health
- Copyright
- © 2020 American Heart Association, Inc.
- ISSN
- 1941-9651
- eISSN
- 1942-0080
- DOI
- 10.1161/CIRCIMAGING.120.010633
- Publisher site
- See Article on Publisher Site
Abstract
Supplemental Digital Content is available in the text.
Journal
Circulation: Cardiovascular Imaging – Wolters Kluwer Health
Published: Nov 1, 2020